A phase III study to evaluate the efficacy and safety of M605110 in patients with acne vulgaris
Active, not recruiting
- Conditions
- Acne vulgaris
- Registration Number
- jRCT2031220334
- Lead Sponsor
- Maruho Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with Acne vulgaris 9 to 49 years old
Exclusion Criteria
(1)Patients with concurrent presense of serious cardiac, hepatic, renal, plumonary, hematologic, or other diseases considered inappropriate for paticipation in the clinical study
(2)Patients with a history of hypersensitivity to investigational drug ingredients
(3)Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- single assignment
- Primary Outcome Measures
Name Time Method - Percentage change in total lesion count
- Secondary Outcome Measures
Name Time Method